Plasma cell characteristics predict benefit from intensified therapy in AL amyloidosis

被引：0
|
作者：
Steinhardt, Maximilian [1 ,2 ,3 ]
Oubari, Sara [4 ]
Cejka, Vladimir [1 ]
Morbach, Caroline [5 ]
Papagianni, Aikaterini [5 ]
Sommer, Claudia [5 ]
Stoerk, Stefan [5 ]
Einsele, Hermann [5 ]
Carpinteiro, Alexander [4 ]
Kortuem, Martin [5 ]
机构：
[1] Julius Maximilians Univ Wurzburg, Wurzburg, Germany
[2] Univ Hosp Wurzburg, Interdisciplinary Amyloidosis Ctr Northern Bavari, Wurzburg, Germany
[3] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[4] Univ Duisburg Essen, Essen, Germany
[5] Univ Hosp Wurzburg, Wurzburg, Germany
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
235
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [1] Primary (AL) amyloidosis in plasma cell disorders
    Mueller, Antonia M. S.
    Geibel, Annette
    Neumann, Hartmut P. H.
    Kuehnemund, Alexander
    Schmitt-Graeff, Annette
    Boehm, Joachim
    Engelhardt, Monika
    ONCOLOGIST, 2006, 11 (07): : 824 - 830
  • [2] Bone Marrow Plasma Cell Infiltration Is a Prognostic Factor for Response to AL Amyloidosis Therapy
    Steinhardt, Maximilian J.
    Cejka, Vladimir
    Morbach, Caroline
    Papagianni, Aikaterini
    Nerreter, Silvia
    Vogt, Cornelia
    Munawar, Umair
    Han, Seungbin
    Rasche, Leo
    Waldschmidt, Johannes M.
    Sommer, Claudia
    Stoerk, Stefan
    Einsele, Hermann
    Kortuem, K. Martin
    BLOOD, 2023, 142
  • [3] Analysis of plasma cell clonality in localized AL amyloidosis
    Setoguchi, M
    Hoshii, Y
    Kawano, H
    Ishihara, T
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2000, 7 (01): : 41 - 45
  • [4] Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis
    Debski, Jakub
    Usnarska-Zubkiewicz, Lidia
    Kapelko-Slowik, Katarzyna
    Pawlus, Aleksander
    Zaleska-Dorobisz, Urszula
    Kuliczkowski, Kazimierz
    TURKISH JOURNAL OF HEMATOLOGY, 2018, 35 (01) : 71 - 72
  • [5] IgD lambda plasma cell neoplasm with extensive AL amyloidosis
    Al Moosawi, Muntadhar
    Varghese, Julia L.
    Merkeley, Hayley
    Parkin, Stephen
    Bahmanyar, Mohammad
    EJHAEM, 2021, 2 (03): : 649 - 650
  • [6] Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis
    Roccatello, Dario
    Fenoglio, Roberta
    Baldovino, Simone
    Naretto, Carla
    Ferro, Michela
    Barreca, Antonella
    Rossi, Daniela
    Sciascia, Savino
    AUTOIMMUNITY REVIEWS, 2020, 19 (09)
  • [7] Autologous stem cell transplantation for AL amyloidosis: a standard therapy?
    Moreau, P
    LEUKEMIA, 1999, 13 (12) : 1929 - 1931
  • [8] Autologous stem cell transplantation for AL amyloidosis: a standard therapy?
    P Moreau
    Leukemia, 1999, 13 : 1929 - 1931
  • [9] PLASMA-CELL PRECURSORS IDENTIFIED BY ANTIIDIOTYPIC ANTIBODIES IN AL AMYLOIDOSIS
    PERFETTI, V
    BELLOTTI, V
    GARINI, P
    MARINONE, MG
    MERLINI, G
    BLOOD, 1994, 84 (10) : A174 - A174
  • [10] Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden
    Schwotzer, Rahel
    Manz, Markus Gabriel
    Pederiva, Stefanie
    Waibel, Christine
    Caspar, Clemens
    Lerch, Erika
    Flammer, Andreas J.
    Brouwers, Sofie
    Seeger, Harald
    Heimgartner, Raphael
    Fehr, Thomas
    Rossi, Davide
    Bianchi, Elena
    Stussi, Georg
    Ghilardi, Guido
    Gerber, Bernhard
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 595 - 600
12345